Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Mersana Therapeutics Inc (NASDAQ: MRSN) closed at $2.16 down -1.37% from its previous closing price of $2.19. In other words, the price has decreased by -$1.37 from its previous closing price. On the day, 1.34 million shares were traded. MRSN stock price reached its highest trading level at $2.22 during the session, while it also had its lowest trading level at $2.13.
Ratios:
For a deeper understanding of Mersana Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.72 and its Current Ratio is at 2.72. In the meantime, Its Debt-to-Equity ratio is 3.83 whereas as Long-Term Debt/Eq ratio is at 2.41.
On February 29, 2024, Wedbush Upgraded its rating to Outperform which previously was Neutral and also upped its target price recommendation from $2 to $7.
Guggenheim Upgraded its Neutral to Buy on February 29, 2024, while the target price for the stock was maintained at $7.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 12 ’24 when Huber Martin H. Jr. sold 50,423 shares for $1.76 per share. The transaction valued at 88,744 led to the insider holds 116,327 shares of the business.
Huber, Martin H. Jr. bought 50,423 shares of MRSN for $89,249 on Sep 12 ’24. On Jan 16 ’24, another insider, Protopapas Anna, who serves as the Director of the company, sold 29,399 shares for $2.71 each. As a result, the insider received 79,671 and left with 125,153 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRSN now has a Market Capitalization of 264978016 and an Enterprise Value of 135169104. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.85 while its Price-to-Book (P/B) ratio in mrq is 31.45. Its current Enterprise Value per Revenue stands at 4.515 whereas that against EBITDA is -1.333.
Stock Price History:
Over the past 52 weeks, MRSN has reached a high of $6.28, while it has fallen to a 52-week low of $1.07. The 50-Day Moving Average of the stock is 25.14%, while the 200-Day Moving Average is calculated to be -23.38%.
Shares Statistics:
For the past three months, MRSN has traded an average of 1.27M shares per day and 1374330 over the past ten days. A total of 120.71M shares are outstanding, with a floating share count of 90.23M. Insiders hold about 26.45% of the company’s shares, while institutions hold 68.12% stake in the company. Shares short for MRSN as of 1724976000 were 10284678 with a Short Ratio of 8.08, compared to 1722384000 on 9113835. Therefore, it implies a Short% of Shares Outstanding of 10284678 and a Short% of Float of 11.020000000000001.
